Search results
What Medicare beneficiaries need to know about generic medications
Fortune· 2 days agoJust ask Susan Jaquith, a retired teacher in Wilson, N.C., who’d been paying about $2,000 a year for a brand-name blood pressure medication and wanted to switch to a less ...
Short-Term Market Volatility Could Provide Long-Term Investing Opportunities
Morningstar· 6 days agoWhy Morningstar thinks Apple could turn it around for 2025. Plus, the Federal Reserve is delaying...
DeMarco wastes no time, wants pledges from congressional nominees on prescription drug costs
Maryland Matters via Yahoo News· 2 days agoCandidates who sign the pledge promise to 'oppose any efforts to weaken the prescription drug affordability provisions in the Inflation Reduction Act.' The post DeMarco wastes ...
Q1 2024 scPharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoWe are encouraged by the prescriber growth in this quarter as we believe it reflects our strategy of establishing a broader prescriber base. Importantly, more than half of these prescribers ...
Today’s political parties seem dumb and dumber; candidate endorsements for Tuesday’s election |...
CapitalGazette.com· 4 days agoHow different are the Democrat and Republican parties? People on the political extremes look at Democrats and Republicans and don’t see a dime’s worth of difference between them. It’s also long ...
JD Supra: The Focus of Federal Proposals on Pharmacy Benefit Management – 118th Congress
JD Supra· 23 hours agoOver the past several years, legislators across the country have focused their attention on Pharmacy Benefit Managers (PBMs) due to concerns expressed over a variety of industry...
Despite Lower Out-Of-Pocket Costs, Insulin Affordability Is Still A Critical Issue
Forbes· 5 days agoIn describing the financial burden caused by the high price of insulin products, a Fortune article...
McDermottPlus Check-Up: May 10, 2024
The National Law Review· 6 days agoThe committee advanced six bills focused on issues related to telehealth, rural health and access to care. The discussion draft includes proposals to...
Q1 2024 Arcutis Biotherapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoWe anticipate the growth trajectory of the foam will likely moderate in the future. But with continued growth, we expect this growth trend to be well along to the large Seb ...
Earnings call: Harrow Inc. reports robust revenue growth in Q1 2024 By Investing.com
Investing.com· 2 days agoHarrow, Inc. (ticker not provided), a prominent player in the ophthalmic pharmaceuticals industry,...
